S-CAP extends pathogenicity prediction to genetic variants that affect RNA splicing

Area of Science:

• Genomics
• Medical Genetics
• Bioinformatics

Background:

• Exome analysis fails to identify causal variants in over 50% of patients with suspected monogenic diseases.
• Splice-disrupting mutations represent a significant class of disease-causing mutations.
• Numerous variants of unknown significance (VUS) in splicing regions complicate genetic diagnosis.

Purpose of the Study:

• To develop a highly sensitive and accurate tool for predicting splicing pathogenicity.
• To improve the diagnostic yield of exome sequencing for rare genetic diseases.

Main Methods:

• Calibration of seven existing splicing pathogenicity prediction tools.
• Development and validation of a novel prediction tool, Splicing Clinically Applicable Pathogenicity prediction (S-CAP).
• Evaluation of S-CAP's performance against existing tools and its ability to distinguish splicing pathogenicity from molecular splicing changes.

Main Results:

• S-CAP demonstrates over twice the predictive power of previous tools.
• S-CAP successfully removes 41% of patient VUS while maintaining 95% sensitivity.
• The tool's performance relies on its unique features, not meta-prediction.

Conclusions:

• S-CAP significantly enhances the prediction of splicing pathogenicity.
• This tool represents a crucial advancement in diagnosing genetic diseases by interpreting non-coding variants.
• S-CAP facilitates the identification of causal diagnoses from exome data.